3Celli BR. Update on the management of COPD. Chest, 2008, 133 : 1451-1462.
4Murray RP, Anthonisen NR, Connett JE, et al. Effects of multiple attempts to quit smoking and relapses to smoking on pulmonary function. Lung Health Study Research Group. J Clin Epidemiol, 1998,51:1317-1326.
5In chronic obstructive pulmonary disease, a combination of iprat- ropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group [ J ]. Chest, 1994,105 : 1411 - 1419.
6Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group[ J ]. Chest, 1997,112 (6) : 1514 - 1521.
7Gross N, Tashkin D, Miller R, et al. Inhalation by nebulization of albuterol-ipratropium combination (Dey combination)is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Dey Combination Solution Study Group [ J ]. Respiration, 1998,65:354 - 362.
8Mahler DA, Wire P, Horstman D, et al. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease[ J]. Am J Respir Crit Care Med,2002,166 : 1084 - 1091.
9Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease : a randomized controlled trial [ J ]. Lancet, 2003,361 : 449 - 456.
10Szafranski W, Cukier A, Ramirez A, et al. Effecacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease [ J ]. Eur Respir J, 2003,21 : 74 - 81.
